Tesa M Severson Selected Research

Tesa M Severson Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2010
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Pathologic Complete Response 08/2017 - 01/2017
1	Acute Promyelocytic Leukemia 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 04/2018
1	Hypersensitivity (Allergy) 04/2018
1	Male Breast Neoplasms (Male Breast Cancer) 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2011
1	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects 12/2010

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 08/2015
4	Hormones (Hormone)IBA 01/2021 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2020
3	Histones (Histone)IBA 01/2021 - 02/2010
3	ChromatinIBA 01/2021 - 06/2016
3	Estrogen Receptor alphaIBA 01/2018 - 06/2016
3	Estrogen ReceptorsIBA 01/2018 - 01/2014
3	Tamoxifen FDA LinkGeneric 06/2016 - 01/2014
2	AndrogensIBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2020 - 12/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2018 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	SteroidsIBA 01/2018 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2016
1	Pharmaceutical PreparationsIBA 01/2022
1	enzalutamideIBA 01/2022
1	Factor V (Coagulation Factor V)IBA 11/2021
1	CCCTC-Binding FactorIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	RON proteinIBA 01/2020
1	macrophage stimulating proteinIBA 01/2020
1	LigandsIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	GSK2879552IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Cytostatic AgentsIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	A 19IBA 04/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2018
1	B7-H1 AntigenIBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	veliparibIBA 01/2017
1	OligonucleotidesIBA 08/2015
1	human ERBB2 proteinIBA 01/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014
1	MTOR InhibitorsIBA 01/2014
1	TensinsIBA 01/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	SterolsIBA 12/2010
1	Histone MethyltransferasesIBA 02/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2014
1	Castration 11/2021